1. Home
  2. TBPH vs AXL Comparison

TBPH vs AXL Comparison

Compare TBPH & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • AXL
  • Stock Information
  • Founded
  • TBPH 2013
  • AXL 1994
  • Country
  • TBPH United States
  • AXL United States
  • Employees
  • TBPH N/A
  • AXL N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • AXL Auto Parts:O.E.M.
  • Sector
  • TBPH Health Care
  • AXL Consumer Discretionary
  • Exchange
  • TBPH Nasdaq
  • AXL Nasdaq
  • Market Cap
  • TBPH 699.0M
  • AXL 715.5M
  • IPO Year
  • TBPH N/A
  • AXL 1999
  • Fundamental
  • Price
  • TBPH $18.81
  • AXL $6.42
  • Analyst Decision
  • TBPH Strong Buy
  • AXL Buy
  • Analyst Count
  • TBPH 4
  • AXL 7
  • Target Price
  • TBPH $24.25
  • AXL $6.93
  • AVG Volume (30 Days)
  • TBPH 569.5K
  • AXL 3.3M
  • Earning Date
  • TBPH 11-10-2025
  • AXL 11-07-2025
  • Dividend Yield
  • TBPH N/A
  • AXL N/A
  • EPS Growth
  • TBPH N/A
  • AXL 46.55
  • EPS
  • TBPH 0.58
  • AXL 0.34
  • Revenue
  • TBPH $80,327,000.00
  • AXL $5,833,600,000.00
  • Revenue This Year
  • TBPH $79.82
  • AXL N/A
  • Revenue Next Year
  • TBPH N/A
  • AXL N/A
  • P/E Ratio
  • TBPH $32.54
  • AXL $18.76
  • Revenue Growth
  • TBPH 27.12
  • AXL N/A
  • 52 Week Low
  • TBPH $7.90
  • AXL $3.00
  • 52 Week High
  • TBPH $18.96
  • AXL $7.03
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 68.84
  • AXL 54.87
  • Support Level
  • TBPH $17.50
  • AXL $5.83
  • Resistance Level
  • TBPH $18.58
  • AXL $6.34
  • Average True Range (ATR)
  • TBPH 0.99
  • AXL 0.32
  • MACD
  • TBPH 0.16
  • AXL -0.01
  • Stochastic Oscillator
  • TBPH 98.49
  • AXL 69.75

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About AXL American Axle & Manufacturing Holdings Inc.

American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.

Share on Social Networks: